![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | A61K 38/17 | (2006.01) |
A61K 39/00 | (2006.01) | ||
C07K 7/06 | (2006.01) | ||
C12N 5/0783 | (2010.01) | ||
C07K 7/08 | (2006.01) |
(11) | Number of the document | 3030255 |
(13) | Kind of document | T |
(96) | European patent application number | 14750175.3 |
Date of filing the European patent application | 2014-08-04 | |
(97) | Date of publication of the European application | 2016-06-15 |
(45) | Date of publication and mention of the grant of the patent | 2019-10-09 |
(46) | Date of publication of the claims translation | 2020-01-27 |
(86) | Number | PCT/EP2014/066755 |
Date | 2014-08-04 |
(87) | Number | WO 2015/018805 |
Date | 2015-02-12 |
(30) | Number | Date | Country code |
201313987 | 2013-08-05 | GB | |
201361862213 P | 2013-08-05 | US | |
201403297 | 2014-02-25 | GB |
(72) |
WEINSCHENK, Toni, DE
WALTER, Steffen, DE
FRITSCHE, Jens, DE
SONG, Colette, DE
SINGH, Harpreet, DE
|
(73) |
immatics biotechnologies GmbH,
Paul-Ehrlich-Strasse 15, 72076 Tübingen,
DE
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Nauja imunoterapija nuo tam tikrų navikų, pavyzdžiui, plaučių vėžio, įskaitant NSLPK |
NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER, INCLUDING NSCLC |
Payment date | Validity (years) | Amount | |
2023-07-24 | 10 | 231.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2024-08-04 |